S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 20.15 CNY -1.03% Market Closed
Market Cap: ¥13.4B

Net Margin

16.3%
Current
Declining
by 0.2%
vs 3-y average of 16.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
16.3%
=
Net Income
¥765m
/
Revenue
¥4.7B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
16.3%
=
Net Income
¥765m
/
Revenue
¥4.7B

Peer Comparison

Country Company Market Cap Net
Margin
CN
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
13.4B CNY
Loading...
US
Medline Inc
NASDAQ:MDLN
62.5B USD
Loading...
JP
Hoya Corp
TSE:7741
9.3T JPY
Loading...
CH
Alcon AG
SIX:ALC
31.8B CHF
Loading...
DK
Coloplast A/S
CSE:COLO B
108.5B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
13.6B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6.2B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
40.9B CNY
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.1B CHF
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
790.8B JPY
Loading...

Market Distribution

Higher than 84% of companies in China
Percentile
84rd
Based on 8 721 companies
84rd percentile
16.3%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Shandong Pharmaceutical Glass Co Ltd
Glance View

Market Cap
13.4B CNY
Industry
Health Care

In the vast landscape of China's industrial might lies Shandong Pharmaceutical Glass Co Ltd., a company serving as a key player in the healthcare and pharmaceutical sectors. Established in 1970, the company has developed a reputation as a leading manufacturer and supplier of pharmaceutical packaging, particularly glass containers. It specializes in producing molded glass and glass tubing that form the backbone of safe and reliable drug delivery systems, including ampoules, vials, and cartridges. Over the decades, Shandong Pharmaceutical Glass Co Ltd. has leveraged its expertise in glass manufacturing to meet stringent industry standards and cater to the ever-evolving needs of its clients, ranging from pharmaceutical giants to smaller biotech firms. At the heart of its business model, Shandong Pharmaceutical Glass generates revenue by providing essential packaging solutions that are integral to the pharmaceutical supply chain. The company's success hinges on its ability to innovate and produce high-quality, durable glass products that ensure the integrity and safety of medicinal products during storage, transportation, and administration. With the rising global demand for pharmaceuticals, particularly in Asia Pacific markets, Shandong Pharmaceutical Glass's focus on sustainable, efficient, and technologically advanced manufacturing processes positions it strategically to capitalize on growth opportunities. By embedding itself in the pharmaceutical lifecycle, the company not only safeguards medications but also fortifies its own standing in a rapidly expanding industry.

Intrinsic Value
28.26 CNY
Undervaluation 29%
Intrinsic Value
Price
S
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
16.3%
=
Net Income
¥765m
/
Revenue
¥4.7B
What is Shandong Pharmaceutical Glass Co Ltd's current Net Margin?

The current Net Margin for Shandong Pharmaceutical Glass Co Ltd is 16.3%, which is below its 3-year median of 16.4%.

How has Net Margin changed over time?

Over the last 3 years, Shandong Pharmaceutical Glass Co Ltd’s Net Margin has increased from 15.2% to 16.3%. During this period, it reached a low of 14.4% on Mar 31, 2023 and a high of 18.5% on Mar 31, 2025.

Back to Top